NCT00845546View on ClinicalTrials.gov

Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

August 31, 2002

Study Completion Date

November 30, 2002

Conditions
Healthy
Interventions
DRUG

10 mg Loratadine/240 mg Pseudoephedrine Sulfate Extended-Release Tablets

Trial Locations (1)

H4R 2N6

MDS Pharma Services, Saint-Laurent

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00845546 - Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter